Enzyme Inhibitor - Global Market Outlook (2016-2022) 

Enzyme Inhibitor - Global Market Outlook (2016-2022) 

  • Published: March 2017
  • ID: SMRC16372

According to Stratistics MRC, the Global Enzyme Inhibitors Market is expected to grow at a CAGR of 4.3% during the forecast period 2016-2022. There has been an exponential rise in the occurrence of various diseases. Enzyme inhibitors are used as diagnostic agents to detect various diseases thus fueling the growth of enzyme inhibitor market. Moreover, usage of these inhibitors in the manufacturing of pesticides and herbicides favours the market growth. However, the existence of strict regulations increases the cost as well as launch period of new drugs, thereby hampering the growth of the global market.

Developing nations of North America and Europe has high growth because of improved diagnosis rate for the diseases, accessibility of medical facility and presence of established infrastructure. Asia Pacific market is expected to flourish due to the existence of large patient pool, enhancing healthcare infrastructure in developing nations such as India, China, and South Korea.

Some of the key players in the market include Amgen, AstraZeneca, Bayer AG, Eli Lilly, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer, Ranbaxy Laboratories Ltd, Roche and Takeda Pharma.

Type of Enzyme Inhibitors Covered:
• Reversible
• Irreversible

End Users Covered:
• Agrochemical
• Pharmaceutical
• Biotechnology
• Food & Beverage
• Other End Users

Disease Indications Covered:
• Arthritis
• Cardiovascular Disease
• Chronic Obstructive Pulmonary Disorders
• Gastrointestinal Disorders
• Inflammatory Diseases
• Other Diseases

Applications Covered:
• Pesticide Synthesis
• Drug Development
• Diagnostic Agent
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary       
         
2 Preface  
      
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology     
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
         
3 Market Trend Analysis      
 3.1 Introduction      
 3.2 Drivers       
 3.3 Restraints      
 3.4 Opportunities      
 3.5 Threats       
 3.6 Application Analysis     
 3.7 End User Analysis      
 3.8 Emerging Markets      
 3.9 Futuristic Market Scenario     
         
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes     
 4.4 Threat of new entrants     
 4.5 Competitive rivalry     
         
5 Global Enzyme Inhibitors Market, By Type    
 5.1 Introduction      
 5.2 Reversible      
 5.3 Irreversible       
         
6 Global Enzyme Inhibitors Market, By End User    
 6.1 Introduction      
 6.2 Agrochemical      
 6.3 Pharmaceutical      
 6.4 Biotechnology      
 6.5 Food & Beverage      
 6.6 Other End Users      
         
7 Global Enzyme Inhibitors Market, By Disease Indication   
 7.1 Introduction      
 7.2 Arthritis       
 7.3 Cardiovascular Disease     
 7.4 Chronic Obstructive Pulmonary Disorders   
 7.5 Gastrointestinal Disorders     
 7.6 Inflammatory Diseases     
 7.7 Other Diseases      
         
8 Global Enzyme Inhibitors Market, By Application    
 8.1 Introduction      
 8.2 Pesticide Synthesis     
 8.3 Drug Development     
 8.4 Diagnostic Agent      
 8.5 Other Applications      
         
9 Global Enzyme Inhibitors Market, By Geography    
 9.1 North America      
  9.1.1 US      
  9.1.2 Canada      
  9.1.3 Mexico      
 9.2 Europe       
  9.2.1 Germany      
  9.2.2 France      
  9.2.3 Italy      
  9.2.4 UK      
  9.2.5 Spain      
  9.2.6 Rest of Europe     
 9.3 Asia Pacific      
  9.3.1 Japan      
  9.3.2 China      
  9.3.3 India      
  9.3.4 Australia      
  9.3.5 New Zealand     
  9.3.6 Rest of Asia Pacific     
 9.4 Rest of the World      
  9.4.1 Middle East     
  9.4.2 Brazil      
  9.4.3 Argentina     
  9.4.4 South Africa     
  9.4.5 Egypt      
         
10 Key Developments       
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 10.2 Acquisitions & Mergers     
 10.3 New Product Launch     
 10.4 Expansions      
 10.5 Other Key Strategies     
         
11 Company Profiling       
 11.1 Amgen       
 11.2 AstraZeneca      
 11.3 Bayer AG      
 11.4 Eli Lilly       
 11.5 Johnson & Johnson     
 11.6 Merck KGaA      
 11.7 Novartis AG      
 11.8 Pfizer       
 11.9 Ranbaxy Laboratories Ltd     
 11.10 Roche       
 11.11 Takeda Pharma 


List of Tables        
1 Global Enzyme Inhibitors Market Outlook, By Region (2014-2022) ($MN)  
2 Global Enzyme Inhibitors Market Outlook, By Type (2014-2022) ($MN)  
3 Global Enzyme Inhibitors Market Outlook, By Reversible (2014-2022) ($MN) 
4 Global Enzyme Inhibitors Market Outlook, By Irreversible (2014-2022) ($MN) 
5 Global Enzyme Inhibitors Market Outlook, By End User (2014-2022) ($MN) 
6 Global Enzyme Inhibitors Market Outlook, By Agrochemical (2014-2022) ($MN) 
7 Global Enzyme Inhibitors Market Outlook, By Pharmaceutical (2014-2022) ($MN) 
8 Global Enzyme Inhibitors Market Outlook, By Biotechnology (2014-2022) ($MN) 
9 Global Enzyme Inhibitors Market Outlook, By Food & Beverage (2014-2022) ($MN) 
10 Global Enzyme Inhibitors Market Outlook, By Other End Users (2014-2022) ($MN) 
11 Global Enzyme Inhibitors Market Outlook, By Disease Indication (2014-2022) ($MN)
12 Global Enzyme Inhibitors Market Outlook, By Arthritis (2014-2022) ($MN) 
13 Global Enzyme Inhibitors Market Outlook, By Cardiovascular Disease (2014-2022) ($MN)
14 Global Enzyme Inhibitors Market Outlook, By Chronic Obstructive Pulmonary Disorders (2014-2022) ($MN)
15 Global Enzyme Inhibitors Market Outlook, By Gastrointestinal Disorders (2014-2022) ($MN)
16 Global Enzyme Inhibitors Market Outlook, By Inflammatory Diseases (2014-2022) ($MN)
17 Global Enzyme Inhibitors Market Outlook, By Other Diseases (2014-2022) ($MN) 
18 Global Enzyme Inhibitors Market Outlook, By Application (2014-2022) ($MN) 
19 Global Enzyme Inhibitors Market Outlook, By Pesticide Synthesis (2014-2022) ($MN)
20 Global Enzyme Inhibitors Market Outlook, By Drug Development (2014-2022) ($MN)
21 Global Enzyme Inhibitors Market Outlook, By Diagnostic Agent (2014-2022) ($MN) 
22 Global Enzyme Inhibitors Market Outlook, By Other Applications (2014-2022) ($MN)
23 North America Enzyme Inhibitors Market Outlook, By Country (2014-2022) ($MN) 
24 North America Enzyme Inhibitors Market Outlook, By Type (2014-2022) ($MN) 
25 North America Enzyme Inhibitors Market Outlook, By Reversible (2014-2022) ($MN)
26 North America Enzyme Inhibitors Market Outlook, By Irreversible (2014-2022) ($MN)
27 North America Enzyme Inhibitors Market Outlook, By End User (2014-2022) ($MN) 
28 North America Enzyme Inhibitors Market Outlook, By Agrochemical (2014-2022) ($MN)
29 North America Enzyme Inhibitors Market Outlook, By Pharmaceutical (2014-2022) ($MN)
30 North America Enzyme Inhibitors Market Outlook, By Biotechnology (2014-2022) ($MN)
31 North America Enzyme Inhibitors Market Outlook, By Food & Beverage (2014-2022) ($MN)
32 North America Enzyme Inhibitors Market Outlook, By Other End Users (2014-2022) ($MN)
33 North America Enzyme Inhibitors Market Outlook, By Disease Indication (2014-2022) ($MN)
34 North America Enzyme Inhibitors Market Outlook, By Arthritis (2014-2022) ($MN) 
35 North America Enzyme Inhibitors Market Outlook, By Cardiovascular Disease (2014-2022) ($MN)
36 North America Enzyme Inhibitors Market Outlook, By Chronic Obstructive Pulmonary Disorders (2014-2022) ($MN)
37 North America Enzyme Inhibitors Market Outlook, By Gastrointestinal Disorders (2014-2022) ($MN)
38 North America Enzyme Inhibitors Market Outlook, By Inflammatory Diseases (2014-2022) ($MN)
39 North America Enzyme Inhibitors Market Outlook, By Other Diseases (2014-2022) ($MN)
40 North America Enzyme Inhibitors Market Outlook, By Application (2014-2022) ($MN)
41 North America Enzyme Inhibitors Market Outlook, By Pesticide Synthesis (2014-2022) ($MN)
42 North America Enzyme Inhibitors Market Outlook, By Drug Development (2014-2022) ($MN)
43 North America Enzyme Inhibitors Market Outlook, By Diagnostic Agent (2014-2022) ($MN)
44 North America Enzyme Inhibitors Market Outlook, By Other Applications (2014-2022) ($MN)
45 Europe Enzyme Inhibitors Market Outlook, By Country (2014-2022) ($MN) 
46 Europe Enzyme Inhibitors Market Outlook, By Type (2014-2022) ($MN)  
47 Europe Enzyme Inhibitors Market Outlook, By Reversible (2014-2022) ($MN) 
48 Europe Enzyme Inhibitors Market Outlook, By Irreversible (2014-2022) ($MN) 
49 Europe Enzyme Inhibitors Market Outlook, By End User (2014-2022) ($MN) 
50 Europe Enzyme Inhibitors Market Outlook, By Agrochemical (2014-2022) ($MN) 
51 Europe Enzyme Inhibitors Market Outlook, By Pharmaceutical (2014-2022) ($MN) 
52 Europe Enzyme Inhibitors Market Outlook, By Biotechnology (2014-2022) ($MN) 
53 Europe Enzyme Inhibitors Market Outlook, By Food & Beverage (2014-2022) ($MN) 
54 Europe Enzyme Inhibitors Market Outlook, By Other End Users (2014-2022) ($MN) 
55 Europe Enzyme Inhibitors Market Outlook, By Disease Indication (2014-2022) ($MN)
56 Europe Enzyme Inhibitors Market Outlook, By Arthritis (2014-2022) ($MN) 
57 Europe Enzyme Inhibitors Market Outlook, By Cardiovascular Disease (2014-2022) ($MN)
58 Europe Enzyme Inhibitors Market Outlook, By Chronic Obstructive Pulmonary Disorders (2014-2022) ($MN)
59 Europe Enzyme Inhibitors Market Outlook, By Gastrointestinal Disorders (2014-2022) ($MN)
60 Europe Enzyme Inhibitors Market Outlook, By Inflammatory Diseases (2014-2022) ($MN)
61 Europe Enzyme Inhibitors Market Outlook, By Other Diseases (2014-2022) ($MN) 
62 Europe Enzyme Inhibitors Market Outlook, By Application (2014-2022) ($MN) 
63 Europe Enzyme Inhibitors Market Outlook, By Pesticide Synthesis (2014-2022) ($MN)
64 Europe Enzyme Inhibitors Market Outlook, By Drug Development (2014-2022) ($MN)
65 Europe Enzyme Inhibitors Market Outlook, By Diagnostic Agent (2014-2022) ($MN) 
66 Europe Enzyme Inhibitors Market Outlook, By Other Applications (2014-2022) ($MN)
67 Asia Pacific Enzyme Inhibitors Market Outlook, By Country (2014-2022) ($MN) 
68 Asia Pacific Enzyme Inhibitors Market Outlook, By Type (2014-2022) ($MN) 
69 Asia Pacific Enzyme Inhibitors Market Outlook, By Reversible (2014-2022) ($MN) 
70 Asia Pacific Enzyme Inhibitors Market Outlook, By Irreversible (2014-2022) ($MN) 
71 Asia Pacific Enzyme Inhibitors Market Outlook, By End User (2014-2022) ($MN) 
72 Asia Pacific Enzyme Inhibitors Market Outlook, By Agrochemical (2014-2022) ($MN)
73 Asia Pacific Enzyme Inhibitors Market Outlook, By Pharmaceutical (2014-2022) ($MN)
74 Asia Pacific Enzyme Inhibitors Market Outlook, By Biotechnology (2014-2022) ($MN)
75 Asia Pacific Enzyme Inhibitors Market Outlook, By Food & Beverage (2014-2022) ($MN)
76 Asia Pacific Enzyme Inhibitors Market Outlook, By Other End Users (2014-2022) ($MN)
77 Asia Pacific Enzyme Inhibitors Market Outlook, By Disease Indication (2014-2022) ($MN)
78 Asia Pacific Enzyme Inhibitors Market Outlook, By Arthritis (2014-2022) ($MN) 
79 Asia Pacific Enzyme Inhibitors Market Outlook, By Cardiovascular Disease (2014-2022) ($MN)
80 Asia Pacific Enzyme Inhibitors Market Outlook, By Chronic Obstructive Pulmonary Disorders (2014-2022) ($MN)
81 Asia Pacific Enzyme Inhibitors Market Outlook, By Gastrointestinal Disorders (2014-2022) ($MN)
82 Asia Pacific Enzyme Inhibitors Market Outlook, By Inflammatory Diseases (2014-2022) ($MN)
83 Asia Pacific Enzyme Inhibitors Market Outlook, By Other Diseases (2014-2022) ($MN)
84 Asia Pacific Enzyme Inhibitors Market Outlook, By Application (2014-2022) ($MN) 
85 Asia Pacific Enzyme Inhibitors Market Outlook, By Pesticide Synthesis (2014-2022) ($MN)
86 Asia Pacific Enzyme Inhibitors Market Outlook, By Drug Development (2014-2022) ($MN)
87 Asia Pacific Enzyme Inhibitors Market Outlook, By Diagnostic Agent (2014-2022) ($MN)
88 Asia Pacific Enzyme Inhibitors Market Outlook, By Other Applications (2014-2022) ($MN)
89 RoW Enzyme Inhibitors Market Outlook, By Country (2014-2022) ($MN)  
90 RoW Enzyme Inhibitors Market Outlook, By Type (2014-2022) ($MN)  
91 RoW Enzyme Inhibitors Market Outlook, By Reversible (2014-2022) ($MN) 
92 RoW Enzyme Inhibitors Market Outlook, By Irreversible (2014-2022) ($MN) 
93 RoW Enzyme Inhibitors Market Outlook, By End User (2014-2022) ($MN)  
94 RoW Enzyme Inhibitors Market Outlook, By Agrochemical (2014-2022) ($MN) 
95 RoW Enzyme Inhibitors Market Outlook, By Pharmaceutical (2014-2022) ($MN) 
96 RoW Enzyme Inhibitors Market Outlook, By Biotechnology (2014-2022) ($MN) 
97 RoW Enzyme Inhibitors Market Outlook, By Food & Beverage (2014-2022) ($MN) 
98 RoW Enzyme Inhibitors Market Outlook, By Other End Users (2014-2022) ($MN) 
99 RoW Enzyme Inhibitors Market Outlook, By Disease Indication (2014-2022) ($MN) 
100 RoW Enzyme Inhibitors Market Outlook, By Arthritis (2014-2022) ($MN)  
101 RoW Enzyme Inhibitors Market Outlook, By Cardiovascular Disease (2014-2022) ($MN)
102 RoW Enzyme Inhibitors Market Outlook, By Chronic Obstructive Pulmonary Disorders (2014-2022) ($MN)
103 RoW Enzyme Inhibitors Market Outlook, By Gastrointestinal Disorders (2014-2022) ($MN)
104 RoW Enzyme Inhibitors Market Outlook, By Inflammatory Diseases (2014-2022) ($MN)
105 RoW Enzyme Inhibitors Market Outlook, By Other Diseases (2014-2022) ($MN) 
106 RoW Enzyme Inhibitors Market Outlook, By Application (2014-2022) ($MN) 
107 RoW Enzyme Inhibitors Market Outlook, By Pesticide Synthesis (2014-2022) ($MN) 
108 RoW Enzyme Inhibitors Market Outlook, By Drug Development (2014-2022) ($MN) 
109 RoW Enzyme Inhibitors Market Outlook, By Diagnostic Agent (2014-2022) ($MN) 
110 RoW Enzyme Inhibitors Market Outlook, By Other Applications (2014-2022) ($MN) 

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials